Nscale vows stay in UK despite £35bn US stock market listing Tech Nscale has vowed to keep Britain at the heart of its global expansion despite choosing New York over London for its blockbuster float, as the AI infrastructure firm looks to turn its UK base into an export hub for computing power. The Nvidia-backed firm believes jobs and expertise built in Britain can serve customers around [...]
Why the Revolut impersonation hack should be a wake-up call for the city Opinion The fact that a company as established as Revolut fell victim to such an attack underlines the threats facing financial services firms, says Graeme Stewart Who am I really talking too? That’s the uncomfortable question that is on everyone’s lips following reports that Revolut has been hit with a $3m ransom demand after a sophisticated impersonation scam. Indeed, the [...]
Will our fiscal psychodrama never end? Economics I’m sure it wasn’t always like this. There was a time, really not that long ago in the grand scheme of things, when trying to predict the contents of an upcoming Budget was limited to dedicated policy wonks and Westminster’s most dogged journalists. These days, fiscal speculation is a major occupation for several months of [...]
London Stock Exchange’s Pisces market set to host third tech deal September 22, 2026 The London Stock Exchange’s fledgling private Pisces market is set to receive another boost after a third tech company unveiled plans for an employee share sale on the platform. Veremark, which uses technology to conduct background checks and screening, will conduct a £6m share sale on the London Stock Exchange’s Private Securities Market (PSM), allowing [...]
Rising hiring costs are ‘holding back Britain’s fastest growing firms’ September 22, 2026 Rising hiring costs and difficulties recruiting talent are making it harder for Britain’s most promising companies to grow, with three quarters saying they could create at least 10 per cent more jobs if barriers to expansion were removed. New research from Enterprise Britain found the cost of employing staff has become one of the main [...]
‘Less allegation’: Brewdog hits out at former owners September 21, 2026 Brewdog’s new owners have sought to distance the company from its founders James Watt and Martin Dickie with a new campaign that pledges the controversial brewer will be “run properly” and attract a “little less allegation”. The craft beer firm, which is now owned by US cannabis firm Tilray, has launched a multi-million pound campaign [...]
Transient Secures Investment from Nasdaq Ventures to Advance Bank-Grade Governance for Enterprise AI September 21, 2026 Transient.AI (“Transient”), the secure AI operating system for regulated markets, announced a strategic investment from Nasdaq Ventures, joining lead investor NEXT Investors in the company’s Series A round. The investment advances Transient’s mission to bring bank-grade, policy-driven AI governance to regulated financial institutions worldwide. As financial leaders assess the security challenges of autonomous AI, enterprise [...]
Premier League front-of-shirt sponsorship revenues rise to £444m September 21, 2026 Premier League clubs’ front-of-shirt sponsorship revenue has risen eight per cent to £444m despite implementing a voluntary ban on gambling firms. The English top flight agreed to ban betting and casino brands from the lucrative front-of-shirt sponsorship slot in a move that lost the 20 clubs a collective £67m. But Premier League teams have managed [...]
A tourist tax will be bad for all business, not just hotels September 21, 2026 Increasing the cost of hotel rooms and Airbnbs is not just a blow to the hospitality sector, it will hammer all businesses, argues James Ford.
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) September 21, 2026 — ALKS 7290 is the First Orexin 2 Receptor Agonist to Demonstrate Clinically Meaningful Improvements in ADHD Symptoms in Adults — — ALKS 7290 Was Generally Well Tolerated at All Doses Tested in Healthy Volunteers and Adults With ADHD — — Phase 2 Study of ALKS 7290 in Adults With ADHD is Enrolling, Data Expected in 2027 —